(Q33475683)

27 July 2017

title

Utility of administrative claims data for the study of brain metastases: a validation study (English)

1 reference

27 July 2017

April F Eichler

1

1 reference

27 July 2017

Elizabeth B Lamont

series ordinal

2

1 reference

27 July 2017

publication date

27 June 2009

1 reference

Journal of Neuro-Oncology

27 July 2017

published in

1 reference

27 July 2017

volume

95

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

427-431

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-009-9943-z

27 July 2017

exact match

0 references

cites work

Brain metastases: epidemiology and pathophysiology.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Neoplasms of the central nervous system: Epidemiologic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Brain metastases: 1995. A brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Epidemiology of brain tumors: the national survey of intracranial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Representation of older patients in cancer treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Identifying cancer relapse using SEER-Medicare data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Studying radiation therapy using SEER-Medicare-linked data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

The utility of Medicare claims data for measuring cancer stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

The accuracy of Medicare's hospital claims data: progress has been made, but problems remain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Use of Medicare hospital and physician data to assess breast cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9943-Z

Participation in cancer clinical trials: race-, sex-, and age-based disparities

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19562256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Demographics of brain metastasis.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19562256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19562256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-009-9943-Z

1 reference

Dimensions Publication ID

27 July 2017

1041398317

0 references

1 reference